Wells Fargo
MIRA icon

Wells Fargo’s MIRA Pharmaceuticals MIRA Stock Holding History

Wells Fargo’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25 Hold
23
– – ﹤0.01% 6749
2025
Q4 		$35 Hold
23
– – ﹤0.01% 6606
2025
Q3 		$31 Buy
+23
New +$33 ﹤0.01% 6596

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $197M AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Wells Fargo's MIRA Position: Q1 2026 in Review

Wells Fargo held its MIRA Pharmaceuticals (MIRA) position steady in Q1 2026 at 23 shares worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #6749.

Wells Fargo first reported a position in MIRA in Q3 2025 and has held it in 3 quarters since. The position peaked at $35 in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • Wells Fargo held 23 shares of MIRA Pharmaceuticals worth $25 as of Q1 2026.
  • Wells Fargo left its MIRA Pharmaceuticals share count unchanged in Q1 2026.
  • MIRA Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6749 holding.
  • Wells Fargo first reported a position in MIRA Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Wells Fargo's MIRA Pharmaceuticals position peaked at $35 in Q4 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.